Richard Romanious
Analyst, Red Eye
Replay available
Oncopeptides AB (publ) (ONCO) Q4 2025 Earnings Call
Oncopeptides AB (publ) (STO: ONCO) Q4 2025 earnings conference call, held 2026-02-19. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Investor Relations Representative
Investor Relations
Henrik Bergentoft
Chief Financial Officer
Sofia Hegis
Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Oncopeptides Ab.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.457 Welcome to Oncopeptide's year-end earnings call for 2025. 00:00:03.457 -- 00:00:08.645 For the first part of the conference call, the participants will be in listen-only mode. 00:00:08.645 -- 00:00:13.353 During the questions and answers session, participants are able to ask questions by dialing 00:00:13.353 -- 00:00:18.782 pound key 5 on their telephone keypad. Now I will hand the conference over to CEO 00:00:18.782 -- 00:00:24.145 Sophia Hagas and CFO Henrik Bergentoft. Please go ahead. 00:00:24.145 -- 00:00:29.657 Hello everyone and welcome to the presentation of Oncopeptide's year-end report 00:00:29.657 -- 00:00:31.621 for 2025. 00:00:31.621 -- 00:00:35.590 My name is Sofia Hegis and I'm the CEO of the company. 00:00:35.590 -- 00:00:40.561 Before we begin, I would like to direct your attention to our standard disclaimer regarding 00:00:40.561 -- 00:00:42.927 forward-looking statements. 00:00:42.927 -- 00:00:48.204 I am joined by our CFO, Henrik Bergentoft, and today we will review a highly 00:00:48.204 -- 00:00:53.641 transformative year for the company and outline a 2026 that brings 00:00:53.641 -- 00:00:56.785 exciting potential. 00:00:57.085 -- 00:01:02.212 Let's look at where we stand today. As we have already communicated, 00:01:02.212 -- 00:01:06.358 we delivered strong commercial progress in 2025, 00:01:06.358 -- 00:01:09.964 with full year net sales more than doubling to 71.1 00:01:09.964 -- 00:01:14.670 million SEK, representing a 125% increase 00:01:14.670 -- 00:01:17.134 compared to 2024. 00:01:17.134 -- 00:01:20.759 For the fourth quarter, net sales reached 18.6 00:01:20.759 -- 00:01:24.104 million SEK, an 88% 00:01:24.104 -- 00:01:27.713 increase compared to the same period in 2024. 00:01:27.713 -- 00:01:32.819 We...